semaglutide being taken off the market FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the Half of Patients Stop Semaglutide

All natural formula that is gluten-free, wheat-free and soy-free

Your prescribing physician and surgical team should communicate directly to establish the safest timeline for your specific situation

Compounded medications are made based on a practitioners prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient

Semaglutide acts on the pancreas to reduce both pre- and post-prandial blood glucose concentrations in a glucose-dependent manner primarily by increasing insulin production and inhibiting the secretion of glucagon

So all in all, Hims & Hers is performing well so far in 2024 even when removing the hyper-scaling obesity segment